FISIOPATOLOGÍA Y FARMACOLOGÍA
Escuela de doctorado
University of Manchester
Mánchester, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Manchester (12)
2023
-
The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment
HEPATOBILIARY SURGERY AND NUTRITION
2022
-
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121
2021
-
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer (British Journal of Cancer, (2020), 123, 7, (1047-1059), 10.1038/s41416-020-0987-3)
British Journal of Cancer
-
Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic
Expert Opinion on Investigational Drugs, Vol. 30, Núm. 4, pp. 377-388
2020
-
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Nature Reviews Gastroenterology and Hepatology, Vol. 17, Núm. 9, pp. 557-588
-
Current and novel therapeutic opportunities for systemic therapy in biliary cancer
British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059
2017
2016
-
Inflammation, glucose, and vascular cell damage: The role of the pentose phosphate pathway
Cardiovascular Diabetology, Vol. 15, Núm. 1
2009
-
Ducts isolated from the pancreas of CFTR-null mice secrete fluid
Pflugers Archiv European Journal of Physiology, Vol. 459, Núm. 1, pp. 203-214
2004
-
Basolateral anion transport mechanisms underlying fluid secretion by mouse, rat and guinea-pig pancreatic ducts
Journal of Physiology, Vol. 556, Núm. 2, pp. 415-428
2001
-
Pancreatic ductal bicarbonate secretion: Past, present and future
Journal of the Pancreas, Vol. 2, Núm. 4, pp. 192-197
-
Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters
Gene Therapy, Vol. 8, Núm. 12, pp. 897-904